Circulating resistin levels were positively correlated with hepatic steatosis, portal inflammation, and NAFLD ACTIVITY SCORES in non-diabetic NAFLD patients [82,83,84,85]. Here, RETN is linked to metabolic dysfunction-associated steatotic liver disease.